Background: Studies report a wide range of incidence and severity of infusion site adverse events (ISAEs) following fosaprepitant administration.
Objectives: The purposes of this study were (a) to determine the incidence of suspected extravasation in patients with cancer receiving fosaprepitant infusions with chemotherapy and (b) to determine whether the documented signs, symptoms, and management strategies aligned with the diagnostic criteria for extravasation versus non-extravasation ISAEs.
Methods: Electronic health records were used to identify patients who received fosaprepitant infusion with chemotherapy and had documentation for suspected extravasation. Chart reviews were conducted for a sample of patients to determine whether documentation was consistent with extravasation.
Findings: About 3% (n = 460 of 15,667) of patients who received fosaprepitant had documentation for suspected extravasation. Among a random sample of patients (N = 110) with suspected extravasation, 6% (n = 6) had documentation consistent with extravasation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492072 | PMC |
http://dx.doi.org/10.1188/20.CJON.E79-E84 | DOI Listing |
BMJ Open
December 2024
Department of Infectious Diseases, Skånes universitetssjukhus Malmö, Malmö, Skåne, Sweden
Objectives: A rising incidence of septic shock as well as recommendations for early vasopressor initiation has increased the number of patients eligible for norepinephrine (NE). Traditionally, NE has been administered through central lines, in intensive care units, due to the risk of extravasation in peripheral lines. The aim of the current study is to determine the rate of complications and patient outcomes when NE is administered through midline catheters (MCs) in intermediary care units (IMCUs).
View Article and Find Full Text PDFNMC Case Rep J
November 2024
Department of Neurosurgery, Division of Clinical Neuroscience, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
Vascular Ehlers-Danlos syndrome (vEDS) is a rare disorder that is characterized by vascular lesions mainly caused by vascular fragility, such as spontaneous carotid-cavernous fistula (sCCF). We experienced a patient who presented with sCCF but suffered postoperative multiple vascular arteriopathy complications caused by undiagnosed vEDS. A 39-year-old woman who had no physical and medical characteristics indicating vEDS was referred to our hospital due to sudden onset of headache and pulsatile tinnitus.
View Article and Find Full Text PDFJ Antimicrob Chemother
November 2024
Infection Management and Prevention Service, The Queensland Children's Hospital, Brisbane, Queensland 4101, Australia.
Eur Heart J Case Rep
November 2024
Department of Cardiology, Tokushima Prefectural Miyoshi Hospital, 815-2 Shima, Ikeda-cho, Miyoshi, Tokushima 778-8503, Japan.
Background: Most coronary artery aneurysms (CAAs) are clinically asymptomatic and are only detected incidentally during cardiac imaging. However, CAAs can cause fatal complications such as cardiac tamponade following a rupture. Reports of contained ruptures of CAAs are limited.
View Article and Find Full Text PDFMedicine (Baltimore)
October 2024
Department of Gastroenterology, The First Hospital of Jilin University, Changchun, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!